Molina Healthcare, Inc $MOH Shares Sold by Mutual Advisors LLC

Mutual Advisors LLC reduced its position in Molina Healthcare, Inc (NYSE:MOH) by 16.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,320 shares of the company’s stock after selling 254 shares during the period. Mutual Advisors LLC’s holdings in Molina Healthcare were worth $393,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of MOH. Price T Rowe Associates Inc. MD lifted its stake in shares of Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after purchasing an additional 1,216,903 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Molina Healthcare by 42.7% in the 1st quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after purchasing an additional 264,664 shares in the last quarter. Nuveen LLC acquired a new position in shares of Molina Healthcare in the 1st quarter valued at about $46,441,000. T. Rowe Price Investment Management Inc. lifted its stake in shares of Molina Healthcare by 8.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after purchasing an additional 117,796 shares in the last quarter. Finally, Durable Capital Partners LP lifted its stake in shares of Molina Healthcare by 13.1% in the 1st quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock valued at $178,399,000 after purchasing an additional 62,899 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO James Woys purchased 10,000 shares of the stock in a transaction dated Monday, August 4th. The stock was purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.26% of the company’s stock.

Molina Healthcare Stock Performance

Shares of MOH opened at $197.52 on Tuesday. The business’s 50 day moving average is $182.80 and its two-hundred day moving average is $242.36. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $359.97. The firm has a market cap of $10.71 billion, a price-to-earnings ratio of 9.73 and a beta of 0.55. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. During the same period in the previous year, the company earned $5.86 earnings per share. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. Analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Morgan Stanley lifted their price objective on Molina Healthcare from $163.00 to $204.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 14th. Mizuho reduced their price target on Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating on the stock in a research report on Friday, July 11th. UBS Group reduced their price target on Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Barclays reduced their price target on Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 4th. Finally, The Goldman Sachs Group assumed coverage on Molina Healthcare in a research report on Tuesday, October 14th. They set a “neutral” rating and a $207.00 price target on the stock. Three equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $222.15.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.